We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Nidan Laboratories & Healthcare Ltd. is an India-based company operating in the healthcare sector, specializing in comprehensive diagnostic services. The company provides an extensive range of pathology services, including biochemistry, hematology, microbiology, cytogenetic, and molecular diagnostic tests. Additionally, it offers a broad spectrum of radiology services such as CT scans, MRI, X-rays, and ultrasounds, along with cardiology and neurology diagnostic services and various health and wellness packages. Nidan Laboratories & Healthcare employs a "one-stop" integrated diagnostic model, serving both retail and institutional clients primarily across Maharashtra, India, particularly within the Mumbai Metropolitan Region. Its operational framework utilizes a "Hub and Spoke" model, featuring a central processing laboratory supported by multiple collection centers and satellite labs, and it is actively expanding its presence into Tier-2 cities through a franchise network.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save NIDAN.NS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
